Slavisa Tubin

Especialização: Radiation oncologist
15 anos de experiência
Local de trabalho: Áustria, Viena, Amethyst Radiotherapy Austria
- Radiation oncology specialist at Amethyst Radiotherapy Austria, described as the developer of the radiovaccine for oncology patients.
- Associated with particle therapy and advanced treatment options including ion beam therapy and proton therapy.
- Clinical technique focus also includes stereotactic photon-based radiotherapy and CyberKnife (lung cancer mentioned in technique set).
- Memberships listed include EORTC and the European Society for Radiotherapy and Oncology (ESTRO).
Slavisa Tubin is a radiation oncology specialist at Amethyst Radiotherapy Austria and is described as the developer of the radiovaccine for oncology patients. His clinical focus spans advanced radiation approaches, including ion beam therapy and proton therapy, alongside stereotactic photon-based radiotherapy and CyberKnife. He is also listed with memberships in EORTC and ESTRO.

Serviços do médico

Como estamos indo?

1 de 3

As informações sobre este médico estão completas e claras

Discordo totalmente

Concordo totalmente

Qualificações

Slavisa Tubin is associated with Amethyst Radiotherapy Austria through an advanced radiation oncology profile that includes the development of a radiovaccine for oncology patients. At Amethyst Radiotherapy Austria, his work is presented in the context of modern cancer care options that go beyond standard radiotherapy. The clinic’s materials describe his expertise in particle therapy approaches such as ion beam therapy and proton therapy, alongside stereotactic photon-based radiotherapy. This combination matters for patients who need highly targeted treatment strategies.

Amethyst also links Tubin’s expertise to stereotactic and robotic radiosurgery approaches, including CyberKnife for lung cancer in the technique set. In addition to clinical work, his professional memberships are listed as EORTC and the European Society for Radiotherapy and Oncology (ESTRO), which signal ongoing engagement with European oncology research and radiotherapy communities. Together, these elements position him as a specialist focused on precision and innovation in radiotherapy planning and delivery.

Education

Not specified in the provided evidence.

Work experience

Radiation oncology specialist — Amethyst Radiotherapy Austria (radiovaccine development mentioned in Amethyst content).
Director for Clinical — MedAustron (as described in MedAustron Facebook video snippet).
Clinical affiliation — Universitätsklinikum Krems (listed on LinkedIn).

Clinical focus and techniques

Slavisa Tubin’s clinical focus is described through advanced radiotherapy modalities and targeted approaches. Amethyst’s materials present him as working with particle therapy and stereotactic techniques, supported by the radiotherapy environment available through partner institutions.

Radiovaccine for oncology patients — described as developed by Dr Slavisa Tubin.
Ion beam therapy — listed among his special focus areas.
Proton therapy and proton-beam therapy — listed techniques.
Stereotaxic radiosurgery — included in the technique set.
CyberKnife — included in the technique set (lung cancer mentioned).

Professional societies and certifications

EORTC (European Organisation for Research and Treatment of Cancer).
European Society for Radiotherapy and Oncology (ESTRO).

Academic output

Not specified in the provided evidence.

Courses and advanced training

Not specified in the provided evidence.

Awards and recognition

Not specified in the provided evidence.

For patients considering radiotherapy in Austria, Amethyst describes consultation pathways that can include online evaluation before an in-person visit. Tubin’s profile is aligned with advanced particle therapy and stereotactic techniques, and his association with Amethyst is presented alongside practice at partner clinical environments in Vienna. If you are looking for a specialist who works at the intersection of innovation (radiovaccine) and advanced radiation modalities, his Amethyst role is built for that purpose.